NG11-2 Phase-Ib Clinical Study Report Complete Gallery NG11-2 Phase-Ib Clinical Study Report Complete By Chloe Atkinson|2025-01-27T13:42:03+00:00January 20th, 2025|News| Read More
New Year’s letter — Looking back on 2024 and our New Year’s Resolutions for 2025 Gallery New Year’s letter — Looking back on 2024 and our New Year’s Resolutions for 2025 By Chloe Atkinson|2025-01-03T10:10:53+00:00January 2nd, 2025|News| Read More
VasoDynamics Receives UK-Taiwan Collaborative R&D Grant Gallery VasoDynamics Receives UK-Taiwan Collaborative R&D Grant By Chloe Atkinson|2024-12-05T11:27:20+00:00November 25th, 2024|News| Read More
VasoDynamics Undertakes Pivotal Trial Scientific Advisory Meeting with Regulatory Authority in the Netherlands to Discuss Next Steps in NG11-2 Development Programme Gallery VasoDynamics Undertakes Pivotal Trial Scientific Advisory Meeting with Regulatory Authority in the Netherlands to Discuss Next Steps in NG11-2 Development Programme By Chloe Atkinson|2024-11-13T12:56:20+00:00October 18th, 2024|Clinical Development, News, NG11| Read More
VasoDynamics strengthens financial management with key appointment to enable progress to market access Gallery VasoDynamics strengthens financial management with key appointment to enable progress to market access By Bradley Shaw|2024-11-13T12:56:38+00:00September 3rd, 2024|Corporate Development, News| Read More
VasoDynamics strengthens the Board with key appointments Gallery VasoDynamics strengthens the Board with key appointments By Chloe Atkinson|2024-12-05T11:08:04+00:00September 2nd, 2024|Corporate Development, News| Read More
NG11-2 Phase-Ib Study Completes Last Patient Visit Gallery NG11-2 Phase-Ib Study Completes Last Patient Visit By Chloe Atkinson|2024-11-13T12:57:16+00:00August 21st, 2024|Clinical Development, News, NG11| Read More
NG11-2 Phase-Ib Study Closes Enrolment – Results Expected Autumn 2024 Gallery NG11-2 Phase-Ib Study Closes Enrolment – Results Expected Autumn 2024 By Chloe Atkinson|2024-11-13T12:57:26+00:00July 1st, 2024|Clinical Development, News, NG11| Read More
VasoDynamics Presents Phase-1b NG11-2 Clinical Data at ESTRO Conference Gallery VasoDynamics Presents Phase-1b NG11-2 Clinical Data at ESTRO Conference By Chloe Atkinson|2024-11-13T12:57:42+00:00May 9th, 2024|Clinical Development, News, NG11| Read More
VasoDynamics Receives Global Health & Pharma Biotechnology 2024 Award Gallery VasoDynamics Receives Global Health & Pharma Biotechnology 2024 Award By Chloe Atkinson|2024-07-31T09:58:58+00:00April 10th, 2024|News| Read More